Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Doctor training aims to ease pain of miscarriage

NCT ID NCT06647849

Symptom relief Sponsor: University Hospital, Angers Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at whether special training for medical interns on how to compassionately announce an early miscarriage can improve the emotional well-being of patients. Over 600 women who had a miscarriage before 14 weeks will be asked about their psychological experience. The goal is to see if better communication from doctors can reduce distress and improve the overall experience.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
simulation training for interns
What this could lead to
If successful, this could lead to better emotional support for women experiencing early pregnancy loss, reducing distress and improving their overall experience.
What could go wrong
This is an early-stage study focused on training, not a direct treatment. Results may not show a clear benefit, and improvements might not be consistent across different hospitals or interns.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

607 people

The number who actually took part.

Started

Nov 2024

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patient * Patient presenting to gynaecological emergency department * Patient with a diagnosis of terminated pregnancy or spontaneous expulsion of a pregnancy \< 14 weeks' amenorrhea * Patient whose spontaneous miscarriage was announced by an intern * Patient affiliated to or benefiting from a social security scheme * Patient having signed an informed consent form Exclusion Criteria: * Unwanted pregnancy * Spontaneous hemorrhagic miscarriage requiring surgical management * Ectopic pregnancy * Miscarriage resulting from assisted reproduction treatment * Patient with history of miscarriage ≥ 3 * Poor understanding of the French language * Person deprived of liberty by judicial or administrative decision * Person under forced psychiatric care * Person subject to a legal protection measure * Person unable to give consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Early pregnancy loss are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Abortion, Spontaneous

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Early pregnancy loss Spontaneous miscarriage

Contacts and locations

Locations

  • CH Chalon-sur-Saône

    Chalon-sur-Saône, France

  • CH Cholet

    Cholet, France

  • CHU Grenoble

    Grenoble, France

  • CHU Nice

    Nice, France

  • CHU Orléans

    Orléans, France

  • Femme Mere Enfant Hospital

    Bron, France

  • Hopital Nord (Marseille Public University Hospital System)

    Marseille, France

  • Jeanne de Flandre Hospital

    Lille, France

  • La Conception Hospital (Marseille Public University Hospital System)

    Marseille, France

  • Le Mans Hospital

    Le Mans, France

  • Poissy intercommunal hospital center

    Poissy, France

  • University Hospital of Amiens

    Amiens, France

  • University Hospital of Angers

    Angers, France

  • University Hospital of Bordeaux

    Bordeaux, France

  • University Hospital of Brest

    Brest, France

  • University Hospital of Caen

    Caen, France

  • University Hospital of Clermont-Ferrand

    Clermont-Ferrand, France

  • University Hospital of Dijon

    Dijon, France

  • University Hospital of Limoges

    Limoges, France

  • University Hospital of Montpellier

    Montpellier, France

  • University Hospital of Nancy

    Nancy, France

  • University Hospital of Nantes

    Nantes, France

  • University Hospital of Nimes

    Nîmes, France

  • University Hospital of Rennes

    Rennes, France

  • University Hospital of Rouen

    Rouen, France

  • University Hospital of Saint Etienne

    Saint-Etienne, France

  • University Hsopital of Reims

    Reims, France

  • Vendée Departmental Hospital center

    La Roche-sur-Yon, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.